The Gairdner Foundation announced the 2022 award laureates in a press release on 5 April 2022, noting that the work of Drs Pieter Cullis, Katalin Kariko and Drew Weissman “enabled the rapid availability of highly effective and safe COVID-19 mRNA vaccines, which has become an important tool for the control of COVID-19 pandemic.”
VANCOUVER, BC (5 April 2022)
Dr. Cullis and colleagues at the University of British Columbia (UBC) and Acuitas Therapeutics, a company he co-founded, developed the indispensable “made in Canada” lipid nanoparticle technology used by these vaccines to deliver mRNA into target cells.
VANCOUVER, BC (24 January 2022)
Pfizer has caught the world’s attention with its promising early results for a COVID-19 vaccine candidate. What has been less widely publicized is the pivotal role of Canadian know-how and technology in the development of this potential vaccine.
VANCOUVER, BC (12 November 2020)
NanoMedicines Innovation Network (NMIN) thought leaders contribute to a commentary in the December 2019 issue of Nature Nanotechnology
VANCOUVER, BC (4 December 2019)